Taiwan Biomaterial Co., Ltd. (6649.TWO)
TWD 34.7
(-0.86%)
TWD 34.7
(-0.86%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -10.16 Million | 35.02 Million | -32 Million | -44.39 Million | -65.43 Million | -60.72 Million |
| Net Income | -10.13 Million | 33.75 Million | -47.44 Million | -55.36 Million | -71.29 Million | -60.54 Million |
| Depreciation & Amortization | 17.86 Million | 16.9 Million | 11.06 Million | 11.83 Million | 11.17 Million | 6.13 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 263 Thousand | - | 3.12 Million | - |
| Change in working capital | -18.71 Million | -15.38 Million | 4.05 Million | -972 Thousand | -8.42 Million | -6.37 Million |
| Other non-cash items | 60.9 Million | 52.32 Million | 16.75 Million | 32.39 Million | 33.87 Million | 12.26 Million |
| Investing Cash Flow | 13.98 Million | -120.55 Million | 48.33 Million | 39.34 Million | -161.04 Million | -3.25 Million |
| Investments in PPE | -3.21 Million | -37.47 Million | -29.69 Million | -150.6 Million | -92.23 Million | -6.15 Million |
| Acquisitions | - | 69 Thousand | - | 52 Thousand | - | - |
| Investment purchases | -31 Thousand | -88.51 Million | -7000.00 | -8000.00 | -77.5 Million | - |
| Sales/Maturities of investments | 17 Million | - | 76.9 Million | 189.8 Million | 8.68 Million | 2.9 Million |
| Other Investing Activities | 226 Thousand | 5.36 Million | 1.14 Million | 106 Thousand | - | - |
| Financing Cash Flow | -15.29 Million | 177.02 Million | 4.5 Million | -3.06 Million | 126.29 Million | 2.06 Million |
| Debt repayment | - | -5.71 Million | -5.71 Million | -730 Thousand | -730 Thousand | -19 Thousand |
| Dividends payments | -8.4 Million | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 189.77 Million | 1.02 Million | - | 130.21 Million | 2.08 Million |
| Other Financing Activities | -6.89 Million | - | - | 52 Thousand | 73 Thousand | - |
| Accounts receivables | 1.65 Million | -13.63 Million | 10.03 Million | -8.6 Million | -3.52 Million | 78 Thousand |
| Accounts payables | 4.62 Million | 2.68 Million | -286 Thousand | 603 Thousand | 405 Thousand | -12 Thousand |
| Inventory | -30.63 Million | -7.81 Million | -4.06 Million | -624 Thousand | -5.29 Million | - |
| Other working capital | 5.64 Million | 3.37 Million | -1.62 Million | 7.65 Million | -7000.00 | -6.43 Million |
| Cash at beginning of period | 183.15 Million | 91.65 Million | 70.81 Million | 78.93 Million | 179.12 Million | 241.04 Million |
| Cash at end of period | 171.67 Million | 183.15 Million | 91.65 Million | 70.81 Million | 78.93 Million | 179.12 Million |
| Capital Expenditure | -3.21 Million | -37.47 Million | -29.69 Million | -150.6 Million | -92.23 Million | -6.15 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -11.47 Million | 91.5 Million | 20.83 Million | -8.12 Million | -100.19 Million | -61.91 Million |
| Free Cash Flow | -13.37 Million | -2.45 Million | -61.7 Million | -195 Million | -157.67 Million | -66.87 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.34 Million | -941 Thousand | -7.46 Million | -10.13 Million | -8.3 Million | 3.44 Million |
| Depreciation & Amortization | 4.41 Million | 4.37 Million | 4.3 Million | 17.86 Million | 4.38 Million | 4.58 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -1.84 Million | -12.96 Million | -8.05 Million | -18.71 Million | -19.2 Million | 14.82 Million |
| Other non-cash items | 10.92 Million | 14.5 Million | 23.22 Million | 60.9 Million | 15.57 Million | 9.05 Million |
| Investing Cash Flow | 9.71 Million | 13.42 Million | 11.77 Million | 13.98 Million | 6.73 Million | -11.65 Million |
| Investments in PPE | -279 Thousand | -1.56 Million | -431 Thousand | -3.21 Million | -770 Thousand | -1.6 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -10 Thousand | -8000.00 | -9000.00 | -31 Thousand | 2.49 Million | -2.5 Million |
| Sales/Maturities of investments | 10 Million | 15 Million | 12 Million | 17 Million | 5 Million | -7.5 Million |
| Other Investing Activities | 173 Thousand | -214 Thousand | 210 Thousand | 226 Thousand | 16 Thousand | -50 Thousand |
| Financing Cash Flow | -1.52 Million | -1.45 Million | -1.45 Million | -15.29 Million | -1.94 Million | -10.12 Million |
| Debt repayment | - | - | - | - | -56 Thousand | -56 Thousand |
| Dividends payments | - | - | - | -8.4 Million | - | -8.4 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.52 Million | - | - | - | - | - |
| Accounts receivables | -2.02 Million | 2.76 Million | -8.88 Million | 1.65 Million | -554 Thousand | 8.98 Million |
| Accounts payables | -1.34 Million | -6.43 Million | 6.28 Million | 4.62 Million | 244 Thousand | -3.4 Million |
| Inventory | 723 Thousand | -2.36 Million | -12.06 Million | -30.63 Million | -6.56 Million | -4.38 Million |
| Other working capital | 806 Thousand | -6.92 Million | 6.62 Million | 5.64 Million | -12.33 Million | 13.63 Million |
| Cash at beginning of period | 173.84 Million | 171.67 Million | 172.63 Million | 183.15 Million | 191.04 Million | 188.9 Million |
| Cash at end of period | 182.71 Million | 173.84 Million | 171.67 Million | 171.67 Million | 172.63 Million | 191.04 Million |
| Capital Expenditure | -279 Thousand | -1.56 Million | -431 Thousand | -3.21 Million | -770 Thousand | -1.6 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 8.86 Million | 2.16 Million | -960 Thousand | -11.47 Million | -18.4 Million | 2.14 Million |
| Free Cash Flow | 401 Thousand | -11.37 Million | -11.7 Million | -13.37 Million | -23.97 Million | 22.32 Million |
KINGSINFR
UAVS
EFOI
VMRI
002145
300006